Predicting Tumor Responses to Gefitinib and Erlotinib

Lignende værker

• Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
  Udgivet: (2012)
• Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib
  af: Nishino, Mizuki, et al.
  Udgivet: (2016)
• Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
  af: Bachawal, Sunitha V, et al.
  Udgivet: (2010)
• Morphologic Features of Adenocarcinoma of the Lung Predictive of Response to the Epidermal Growth Factor Receptor Kinase Inhibitors Erlotinib and Gefitinib
  af: Zakowski, Maureen F., et al.
  Udgivet: (2009)
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
  af: Pao, William, et al.
  Udgivet: (2005)